The Trade War’s Pharma Carve-Out
Both the U.S. and China have held off on tariffing each other’s pharmaceuticals.
Articles
Chagee’s Last-Gasp Listing
Tea chain Chagee listed on the Nasdaq as calls mount to bar Chinese stocks from the U.S. markets.
Wall Street’s CATL Dilemma
The battery giant’s Hong Kong IPO has put big American banks in Washington’s crosshairs.
Oren Cass on The Benefits of Tariffs
The economist discusses the need for a new global trading system.
China’s Rare Earths Riposte
China’s retaliation to U.S. tariffs included export controls of seven rare earth elements.
The Road to TikTok’s D-Day
A look at how the U.S. government's approach to the wildly popular social media app has twisted and turned.
Baichuan’s Big Pivot
One of China’s so-called AI tigers has made big changes to its leadership and strategy this year.
Intel’s Surprising Savior
The new leader of America’s chip champion is a prolific and longtime investor in China’s semiconductor industry.
Missouri’s Multibillion Challenge to China
Missouri sued China for hoarding PPE during the pandemic and won $24.5 billion. Its efforts to collect could get muddy.
China’s Open-Source Embrace
Chinese AI firms and chipmakers have become increasingly open to making their technology secrets available to all-comers.
China’s Waning Oil Thirst
China’s oil imports are showing signs of reaching a peak.
China Hawks Stop Squawking
The Trump administration’s early moves on China are making some Republicans nervous, though few are openly voicing their doubts.